The DOI matches its Crossref record; 215 of the 235 references it cites were found in a registry or an index; 37 of the 152 sources its claims cite were checked for support.
Marine Natural Products: A Source of Novel Anticancer Drugs
Open accessAbstract
Cancer remains one of the most lethal diseases worldwide. There is an urgent need for new drugs with novel modes of action and thus considerable research has been conducted for new anticancer drugs from natural sources, especially plants, microbes and marine organisms. Marine populations represent reservoirs of novel bioactive metabolites with diverse groups of chemical structures. This review highlights the impact of marine organisms, with particular emphasis on marine plants, algae, bacteria, actinomycetes, fungi, sponges and soft corals. Anti-cancer effects of marine natural products in in vitro and in vivo studies were first introduced; their activity in the prevention of tumor formation and the related compound-induced apoptosis and cytotoxicities were tackled. The possible molecular mechanisms behind the biological effects are also presented. The review highlights the diversity of marine organisms, novel chemical structures, and chemical property space. Finally, therapeutic strategies and the present use of marine-derived components, its future direction and limitations are discussed.
Overview
CoChat Summary
TL;DR
This review summarizes marine natural products as sources of novel anticancer drugs, covering marine plants, algae, bacteria, actinomycetes, fungi, sponges, and soft corals. It highlights cytotoxic and mechanistic findings, clinical candidates, and chemical property-space diversity, while noting that many marine compounds remain preclinical and the deep sea is largely unexplored.
Key findings
- Marine-derived compounds show anticancer activity across many tumor cell lines: cryptophycin 1 had IC50 = 0.005 and 0.003 ng/mL against KB and LOVO cells; coibamide A had LC50 < 23 nM against NCIH460 lung and mouse neuro-2a cells; salinosporamide A had IC50 = 0.13, 0.28, 7.5, and 35.0 µM against A-549, HL-60, BEL-7402, and P388 cells, respectively.
- The review reports 13 natural products isolated from marine organisms being tested in different phases of clinical trials; examples include bryostatin 1 in phase II, ET-743 in phase I, and dolastatin 10 in phase II. Marine-based drugs cited as used against leukemia, metastatic breast cancer, soft tissue sarcoma, and ovarian cancer include cytarabine, eribulin mesylate, brentuximab vedotin, and trabectidine.
- Marine biodiversity is described as vast: oceans cover over 70% of the earth, nearly 250,000 marine species are described, 99% of all bacteria cannot be cultured, and there are more than 22,000 known microbial secondary metabolites, 70% produced by actinomycetes, 20% by fungi, 7% by Bacillus spp., and 1–2% by other bacteria.
- ChemGPS-NP analysis using eight principal components based on 35 molecular descriptors showed that the reviewed marine compounds did not form tight clusters, indicating chemical diversity within classes such as marine peptides.
Methods
- Narrative review of marine natural products with anticancer activity, emphasizing marine plants, algae, bacteria, actinomycetes, fungi, sponges, and soft corals, and covering in vitro, in vivo, and clinical trial reports.
- For chemical property space, chemical structures were converted to SMILES using Chemsketch and submitted to ChemGPS-NPweb; eight principal component values were obtained from 35 molecular descriptors per compound, and PC1, PC2, and PC3 were plotted in three dimensions.
- Main analysis is qualitative synthesis of reported cytotoxic activities, mechanisms, and clinical status; no systematic search strategy, inclusion criteria, or quantitative meta-analysis is described.
Limitations
- Stated in the paper: sampling difficulties and the need for sufficiently large quantities for detailed analyses; less than 5% of the deep sea has been explored and less than 0.01% of the deep-sea floor sampled in detail; preclinical and clinical data for marine natural compound chemoprevention remain scant; NMR is less sensitive than MS and some compound classes cannot be detected by MS; many compounds such as calothrixins A/B, ulithiacyclamide, patellamide, borophycin, and largazole have not yet entered clinical trials; the exact mechanism of sansalvamide A is unknown.
- Evident from the text: as a narrative review, it lacks a systematic search strategy, formal inclusion/exclusion criteria, risk-of-bias assessment, and quantitative pooling, so the findings are illustrative rather than exhaustive.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures









Verification
Claims the paper makes
32 Valid · 3 Not valid · 64 Not checked · 11 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Advanced technology and extensive research on marine natural products have led to the discovery of a new generation of anticancer drugs currently used in clinical trials [6].”
§ Marine Natural Products: A Source of Novel Anticancer Drugs > 1. Introduction
What the sources say
- Partly supportedcites [6] Ang, 2000, In vivo antimalarial activity of the beta-carboline alkaloid manzamine A, Antimicrob. Agents Chemother. sourceExperimental — accuracy not yet measured
The Abstract (page not specified) says marine-sponge manzamines had attracted interest as potential anticancer agents and inhibited cancer-cell growth. It does not say that advanced technology produced a new generation of anticancer drugs or that any were in clinical trials; this paper reports antimalarial testing in mice. (LLM, conf=0.87)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Natural bioactive molecules exhibit cytotoxic effects by attacking macromolecules expressed by cancer cells, such as those in oncogenic signal transduction pathways [16].”
§ Marine Natural Products: A Source of Novel Anticancer Drugs > 1. Introduction
What the sources say
- Supportedcites [16] Nobili, 2009, Natural compounds for cancer treatment and prevention, Pharmacol. Res. source
The Conclusions describe natural compounds with cytotoxic activity that target macromolecules in cancer cells, including compounds targeting oncogenic signal-transduction pathways. The citing sentence paraphrases that distinction. (LLM, conf=0.93)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Over the past 50 years, emerging evidence has shown that many natural products derived from plants and microbes of marine origin (Table 1), exhibit beneficial effects in the prevention and treatment of cancer, i.e., cytarabine, eribulin mesylate, brentuximab vedotin, and trabectidine are marine-based drugs used against leukemia, metastatic breast cancer, soft tissue sarcoma and ovarian cancer [20,”
§ Marine Natural Products: A Source of Novel Anticancer Drugs > 2. Nature and Cancer Chemotherapy
What the sources say
- Partly supportedcites [20] Dyshlovoy, S.A., and Honecker, F. (2018). Marine compounds and cancer: 2017 updates. Mar. Drugs, 16. sourceExperimental — accuracy not yet measured
The paper’s main text reports anticancer activity in compounds from marine algae and microbes and identifies four marine-derived drugs approved to treat cancer. It does not establish beneficial effects in cancer prevention, so the prevention portion of the claim is unsupported. (LLM, conf=0.85)
- Not matchedcites [21] (2019, August 17). Drug Bank. Available online: http://www.drugbank.ca.
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The bryostatin 1 has recently entered phase II clinical trial against melanoma, non-Hodgkin’s lymphoma, renal cancer and colorectal cancer [58,59,60].”
§ Marine Natural Products: A Source of Novel Anticancer Drugs > 5. From Marine Organisms to Anticancer Drugs
What the sources say
- Not checked — no full text of the sourcecites [58] Bourhill, 2017, Enzastaurin: A lesson in drug development, Crit. Rev. Oncol. Hematol. source
- Partly supportedcites [59] Wang, 2013, Marine-derived angiogenesis inhibitors for cancer therapy, Mar. Drugs sourceExperimental — accuracy not yet measured
Section 4.1 reports phase I and II bryostatin-1 trials involving all four named cancers, and the References list phase II studies for each, including colorectal cancer (ref. 132). But the paper says more than 80 phase I and II trials had been conducted since 1993; it does not support the claim that bryostatin-1 had recently entered phase II trials. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [60] Ritchie, 2015, Cancer research UK centre for drug development: Translating 21st-century science into the cancer medicines of tomorrow, Drug Discov. Today source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“Based on modern research, cultured benthic cyanobacteria from temperate marine environments provide a promising, under-exploited source for novel drugs against leukemia [107].”
§ Marine Natural Products: A Source of Novel Anticancer Drugs > 5. From Marine Organisms to Anticancer Drugs > 5.1. Marine Plants
What the sources say
- Could not verifycites [107] Peng, 2010, Structure and absolute configuration of karlotoxin-2, an ichthyotoxin from the marine dinoflagellate Karlodinium veneficum, J. Am. Chem. Soc. sourceExperimental — accuracy not yet measured
The Abstract describes karlotoxin-2 from the marine dinoflagellate Karlodinium veneficum and its toxicity to fish. Searches for benthic cyanobacteria and leukemia found no passage addressing their potential as a source of leukemia drugs. (LLM, conf=0.77)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Could not verify
69 more claims · 15 with their cited sources checked
Create a free account to see all 110 claims and to verify the 12 references still open.
- It may state two separate claims as one. 23
- Probably not a substantial claim. 18
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Marine Natural Products: A Source of Novel Anticancer Drugs > 5. From Marine Organisms to Anticancer Drugs > 5.1. Marine Plants
“against KB cells and 5 µg/mL against LOVO cells (colon cancer)”
§ Marine Natural Products: A Source of Novel Anticancer Drugs > 5. From Marine Organisms to Anticancer Drugs > 5.1. Marine Plants
“against human epidermoid carcinoma (LOVO) and human colorectal adenocarcinoma (KB) cell lines”
Citations
Cites
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109 · cited 2×
“In 2018, approximately 18 million new cases of cancer reported globally, resulting in approximately 10 million deaths [1].”
BackgroundCancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29210 · Cited by 28,766
Natural products as sources of new drugs from 1981 to 2014
Newman, D. J., & Cragg, G. M. (2016) · Journal of Natural Products · doi:10.1021/acs.jnatprod.5b01055 · Cited by 5,858
Natural products as sources of new drugs over the last 25 years
Newman, D. J., & Cragg, G. M. (2007) · Journal of Natural Products · doi:10.1021/np068054v · Cited by 5,517
Prokaryotes: The unseen majority
Whitman, W. B., Coleman, D. C., & Wiebe, W. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.12.6578 · Cited by 4,871
Natural products as sources of new drugs over the 30 years from 1981 to 2010
Newman, D. J., & Cragg, G. M. (2012) · Journal of Natural Products · doi:10.1021/np200906s · Cited by 4,687 · cited 2×
“Approximately 80% of the approved chemotherapeutic drugs [13], and more than half of all drugs are based on bioactive natural products [14].”
BackgroundBioactive Microbial Metabolites: A Personal View
Bérdy, J. (2005) · The Journal of Antibiotics · doi:10.1038/ja.2005.1 · Cited by 3,170 · cited 1×
“Of these actinomycete-derived compounds, 75% were derived from Streptomyce whereas 25% were derived from rare actinomycetes [125,126].”
BackgroundNatural products as sources of new drugs over the period 1981–2002
Newman, D. J., Cragg, G. M., & Snader, K. M. (2003) · Journal of Natural Products · doi:10.1021/np030096l · Cited by 3,082 · cited 1×
“Approximately 80% of the approved chemotherapeutic drugs [13], and more than half of all drugs are based on bioactive natural products [14].”
BackgroundMedicinal plants: Traditions of yesterday and drugs of tomorrow
Gurib-Fakim, A. (2006) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2005.07.008 · Cited by 2,391 · cited 1×
“The incidence of cancer continues to increase due to environmental changes and life style modernization [3].”
BackgroundShahidi, F., Janitha, P. K., & Wanasundara, P. D. (1992) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408399209527581 · Cited by 2,238
Cyanobacteria secondary metabolites—the cyanotoxins
Carmichael, W. W. (1992) · Journal of Applied Bacteriology · doi:10.1111/j.1365-2672.1992.tb01858.x · Cited by 1,457
The role of natural product chemistry in drug discovery
Butler, M. S. (2004) · Journal of Natural Products · doi:10.1021/np040106y · Cited by 1,381 · cited 1×
“Natural products represent an available source of new drugs, drug leads and chemical entities [11,12].”
BackgroundThe influence of natural products upon drug discovery (Antiquity to late 1999)
Newman, D. J., Cragg, G. M., & Snader, K. M. (2000) · Natural Product Reports · doi:10.1039/a902202c · Cited by 1,293 · cited 1×
“These compounds were found to possess antiviral activity and synthetic analogs studies eventually led to the development of cytosine arabinoside (AraC) as a clinically anticancer agent [148].”
BackgroundCortes, J., O'Shaughnessy, J., Loesch, D., Blum, J. L., Vahdat, L. T., Petrakova, K., Chollet, P., Manikas, A., Diéras, V., Delozier, T., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60070-6 · Cited by 1,094
Feling, R. H., Buchanan, G. O., Mincer, T. J., Kauffman, C. A., Jensen, P. R., & Fenical, W. (2003) · Angewandte Chemie International Edition · doi:10.1002/anie.200390115 · Cited by 1,057
Fries, E., Dekiff, J. H., Willmeyer, J., Nuelle, M.-T., Ebert, M., & Remy, D. (2013) · Environmental Science: Processes & Impacts · doi:10.1039/c3em00214d · Cited by 926
Deep, diverse and definitely different: Unique attributes of the world’s largest ecosystem
Ramirez-Llodra, E., Brandt, A., Danovaro, R., De Mol, B., Escobar, E., German, C. R., Levin, L. A., Martinez Arbizu, P., Menot, L., Buhl-Mortensen, P., et al. (2010) · Biogeosciences · doi:10.5194/bg-7-2851-2010 · Cited by 913
Tewey, K. M., Chen, G. L., Nelson, E. M., & Liu, L. F. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)47282-6 · Cited by 887
Natural compounds for cancer treatment and prevention
Nobili, S., Lippi, D., Witort, E., Donnini, M., Bausi, L., Mini, E., & Capaccioli, S. (2009) · Pharmacological Research · doi:10.1016/j.phrs.2009.01.017 · Cited by 780 · cited 4×
“Given the great potential of marine natural product scaffolds, there is an increasing interest for exploiting this diversity and complexity for rational drug discovery [16].”
BackgroundInfluentialBerteau, O. (2003) · Glycobiology · doi:10.1093/glycob/cwg058 · Cited by 769
White, M. C., Holman, D. M., Boehm, J. E., Peipins, L. A., Grossman, M., & Jane Henley, S. (2014) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2013.10.029 · Cited by 762 · cited 3×
“[2], have been investigated for cancer control [39,40].”
BackgroundDrugs from the deep: Marine natural products as drug candidates
Haefner, B. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02713-2 · Cited by 740
A perspective on multi‐target drug discovery and design for complex diseases
Ramsay, R. R., Popovic‐Nikolic, M. R., Nikolic, K., Uliassi, E., & Bolognesi, M. L. (2018) · Clinical and Translational Medicine · doi:10.1186/s40169-017-0181-2 · Cited by 718 · cited 1×
“The progress in biological, immunotherapy and the substantial improvements in modern drug design and manufacturing have made the discovery of a cure for cancer a feasible goal [4].”
BackgroundChauhan, D., Catley, L., Li, G., Podar, K., Hideshima, T., Velankar, M., Mitsiades, C., Mitsiades, N., Yasui, H., Letai, A., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.10.013 · Cited by 694
Natural products in anticancer therapy
da Rocha, A. (2001) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(01)00063-7 · Cited by 604
Marine natural products as anticancer drugs
Simmons, T. L., Andrianasolo, E., McPhail, K., Flatt, P., & Gerwick, W. H. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.333.4.2 · Cited by 597
Schmidt, E. W., Nelson, J. T., Rasko, D. A., Sudek, S., Eisen, J. A., Haygood, M. G., & Ravel, J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501424102 · Cited by 567
Protective role of probiotics and prebiotics in colon cancer
Wollowski, I., Rechkemmer, G., & Pool-Zobel, B. L. (2001) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/73.2.451s · Cited by 560 · cited 1×
“Probiotic bacteria, such as Lactobacilli and Bifidobacteria, produce anticancer substances [113].”
BackgroundBioactivities, bioactive compounds and chemical constituents of mangrove plants
Bandaranayake, W. M. (2002) · Wetlands Ecology and Management · doi:10.1023/a:1021397624349 · Cited by 550 · cited 2×
“Also known as seaweed, multicellular macroalgae contain numerous pharmacologically important bioactive elements to include carotenoids, dietary fiber, protein, essential fatty acids, vitamins (A, B, B12, C, D, E), and minerals such as Ca, P, Na, and K [70–73], in addition to polyphenols [74,75].”
BackgroundDiscovery of novel metabolites from marine actinomycetes
Lam, K. S. (2006) · Current Opinion in Microbiology · doi:10.1016/j.mib.2006.03.004 · Cited by 539
Bioactive natural products from marine cyanobacteria for drug discovery
Tan, L. T. (2007) · Phytochemistry · doi:10.1016/j.phytochem.2007.01.012 · Cited by 534 · cited 1×
“, dolastatin 10 and curacin A, have been clinically evaluated for the treatment of cancer and to serve as lead structures for the synthesis of a number of synthetic analogs/derivatives [88].”
BackgroundHalichondrins-antitumor polyether macrolides from a marine sponge
Hirata, Y., & Uemura, D. (1986) · Pure and Applied Chemistry · doi:10.1351/pac198658050701 · Cited by 519
Sánchez-Moreno, C., A. Larrauri, J., & Saura-Calixto, F. (1999) · Food Research International · doi:10.1016/s0963-9969(99)00097-6 · Cited by 472
Actinomycetes: Still a source of novel antibiotics
Genilloud, O. (2017) · Natural Product Reports · doi:10.1039/c7np00026j · Cited by 465 · cited 1×
“Actinomycetes are undoubtedly the largest producers of secondary metabolites among marine microorganisms [124].”
BackgroundTaori, K., Paul, V. J., & Luesch, H. (2008) · Journal of the American Chemical Society · doi:10.1021/ja7110064 · Cited by 428 · cited 1×
“with impressive anti-proliferative activity [98].”
Bergmann (1951) · doi:10.1021/jo01146a023 · Cited by 403
Trabectedin plus pegylated liposomal doxorubicin in recurrent ovarian cancer
Monk, B. J., Herzog, T. J., Kaye, S. B., Krasner, C. N., Vermorken, J. B., Muggia, F. M., Pujade-Lauraine, E., Lisyanskaya, A. S., Makhson, A. N., Rolski, J., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.4037 · Cited by 395
Anticancer Drugs from Marine Flora: An Overview
Sithranga Boopathy, N., & Kathiresan, K. (2010) · Journal of Oncology · doi:10.1155/2010/214186 · Cited by 394 · cited 7×
“The other potent group of compounds that is abundantly present in several marine organisms is polysaccharides (Figure 5; Table 1), primarily alginates, agar, and carrageenans [31].”
BackgroundInfluentialGanesan, P., Kumar, C. S., & Bhaskar, N. (2008) · Bioresource Technology · doi:10.1016/j.biortech.2007.07.005 · Cited by 393
Immense essence of excellence: Marine microbial bioactive compounds
Bhatnagar, I., & Kim, S.-K. (2010) · Marine Drugs · doi:10.3390/md8102673 · Cited by 384 · cited 1×
“Cyanobacteria produce a family of antitumor agents known as cryptophycins, which interfere with tubulin assembly [101].”
BackgroundLuesch, H., Moore, R. E., Paul, V. J., Mooberry, S. L., & Corbett, T. H. (2001) · Journal of Natural Products · doi:10.1021/np010049y · Cited by 378 · cited 1×
“The parental compound, apratoxin A, isolated from a strain of Lyngbya boulloni, exhibited cytotoxicity against adenocarcinoma [99].”
BackgroundActinomycetes for marine drug discovery isolated from mangrove soils and plants in China
Hong, K., Gao, A.-H., Xie, Q.-Y., Gao, H. G., Zhuang, L., Lin, H.-P., Yu, H.-P., Li, J., Yao, X.-S., Goodfellow, M., et al. (2009) · Marine Drugs · doi:10.3390/md7010024 · Cited by 372
Gerwick, W. H., Proteau, P. J., Nagle, D. G., Hamel, E., Blokhin, A., & Slate, D. L. (1994) · The Journal of Organic Chemistry · doi:10.1021/jo00085a006 · Cited by 365 · cited 1×
“Curacin A, isolated from the organic extracts of Curacao collections of Lyngbya majuscule, is an exceptionally potent anti-proliferative agent that inhibited tubulin polymerization and also exhibited selective inhibitory activity against leukemia and Burkitt lymphoma cell lines (IC50 = 9 nM and 200 nM) [104,105].”
BackgroundAntitumor compounds from marine actinomycetes
Olano, C., Méndez, C., & Salas, J. A. (2009) · Marine Drugs · doi:10.3390/md7020210 · Cited by 330 · cited 1×
“Of these actinomycete-derived compounds, 75% were derived from Streptomyce whereas 25% were derived from rare actinomycetes [125,126].”
BackgroundMarine actinomycete diversity and natural product discovery
Jensen, P. R., Mincer, T. J., Williams, P. G., & Fenical, W. (2005) · Antonie van Leeuwenhoek · doi:10.1007/s10482-004-6540-1 · Cited by 325
Dolastatin 10, a powerful cytostatic peptide derived from a marine animal
Bai, R., Petit, G. R., & Hamel, E. (1990) · Biochemical Pharmacology · doi:10.1016/0006-2952(90)90613-p · Cited by 321 · cited 1×
“Moreover, ET-743, a tetrahydroisoquinilone alkaloid isolated from tunicate Ecteinascidia turbinata entered phase I clinical trials [62], since it exerts anti-proliferative effects by selective alkylation of guanine residues in the DNA minor groove [63], whereas dolastatin 10, a member of a peptide family isolated from…”
BackgroundMaldonado, L. A., Fenical, W., Jensen, P. R., Kauffman, C. A., Mincer, T. J., Ward, A. C., Bull, A. T., & Goodfellow, M. (2005) · International Journal of Systematic and Evolutionary Microbiology · doi:10.1099/ijs.0.63625-0 · Cited by 317
Aisa, Y., Miyakawa, Y., Nakazato, T., Shibata, H., Saito, K., Ikeda, Y., & Kizaki, M. (2005) · American Journal of Hematology · doi:10.1002/ajh.20182 · Cited by 307 · cited 1×
“This effect was explained by the consequent activation of caspase-3 and down regulation of the kinase pathway [179].”
BackgroundTrimurtulu, G., Ohtani, I., Patterson, G. M. L., Moore, R. E., Corbett, T. H., Valeriote, F. A., & Demchik, L. (1994) · Journal of the American Chemical Society · doi:10.1021/ja00090a020 · Cited by 303 · cited 1×
“003 ng/mL)) and in vivo (human solid tumors (colon adenocarcinomas, pancreatic ductal adenocarcinoma and mammary adenocarcinoma) [96,97].”
BackgroundDiscovery and development of the anticancer agent salinosporamide A (NPI-0052)
Fenical, W., Jensen, P. R., Palladino, M. A., Lam, K. S., Lloyd, G. K., & Potts, B. C. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.10.075 · Cited by 291
Total phenolic contents and antioxidant activity of corn tassel extracts
Mohsen, S. M., & Ammar, A. S. M. (2009) · Food Chemistry · doi:10.1016/j.foodchem.2008.06.014 · Cited by 286
A global assembly line for cyanobactins
Donia, M. S., Ravel, J., & Schmidt, E. W. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.84 · Cited by 279
Cyclic peptides and depsipeptides from cyanobacteria: A review
Moore, R. E. (1996) · Journal of Industrial Microbiology · doi:10.1007/bf01570074 · Cited by 277 · cited 1×
“003 ng/mL)) and in vivo (human solid tumors (colon adenocarcinomas, pancreatic ductal adenocarcinoma and mammary adenocarcinoma) [96,97].”
BackgroundTHE ISOLATION OF A NEW THYMINE PENTOSIDE FROM SPONGES1
Bergmann, W., & Feeney, R. J. (1950) · Journal of the American Chemical Society · doi:10.1021/ja01162a543 · Cited by 267 · cited 1×
“The Caribbean sponge (Cryptotethya crypta) was the first marine organism to be investigated in detail chemically [33], and extensive phytochemical studies on pure compounds from this organism were performed from 1950 to 1960, before the identification of cytosine arabinoside (ara-C) [34–36].”
BackgroundEcteinascidin-743 (ET-743), a natural marine compound, with a unique mechanism of action
Erba, E., Bergamaschi, D., Bassano, L., Damia, G., Ronzoni, S., Faircloth, G. T., & D'Incalci, M. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(00)00357-9 · Cited by 262 · cited 1×
“Moreover, ET-743, a tetrahydroisoquinilone alkaloid isolated from tunicate Ecteinascidia turbinata entered phase I clinical trials [62], since it exerts anti-proliferative effects by selective alkylation of guanine residues in the DNA minor groove [63], whereas dolastatin 10, a member of a peptide family isolated from…”
BackgroundNatural combinatorial peptide libraries in cyanobacterial symbionts of marine ascidians
Donia, M. S., Hathaway, B. J., Sudek, S., Haygood, M. G., Rosovitz, M. J., Ravel, J., & Schmidt, E. W. (2006) · Nature Chemical Biology · doi:10.1038/nchembio829 · Cited by 261
Marine organisms as a source of new anticancer agents
Schwartsmann, G., da Rocha, A. B., Berlinck, R. G., & Jimeno, J. (2001) · The Lancet Oncology · doi:10.1016/s1470-2045(00)00292-8 · Cited by 261
Mans, D. R. A., Rocha, A. B., & Schwartsmann, G. (2000) · The Oncologist · doi:10.1634/theoncologist.5-3-185 · Cited by 254 · cited 2×
“Also known as seaweed, multicellular macroalgae contain numerous pharmacologically important bioactive elements to include carotenoids, dietary fiber, protein, essential fatty acids, vitamins (A, B, B12, C, D, E), and minerals such as Ca, P, Na, and K [70–73], in addition to polyphenols [74,75].”
BackgroundNewman, D., & Cragg, G. (2014) · Marine Drugs · doi:10.3390/md12010255 · Cited by 250 · cited 1×
“A significant number of marine-derived metabolites act as antitumor agents via potent growth inhibition of human tumor cells both in vitro, in vivo (in murine) models and in cancer clinical trials [13,17].”
BackgroundBhadury, P., Mohammad, B. T., & Wright, P. C. (2006) · Journal of Industrial Microbiology & Biotechnology · doi:10.1007/s10295-005-0070-3 · Cited by 250
Rickards, R. W., Rothschild, J. M., Willis, A. C., de Chazal, N. M., Kirk, J., Kirk, K., Saliba, K. J., & Smith, G. D. (1999) · Tetrahedron · doi:10.1016/s0040-4020(99)00833-9 · Cited by 249 · cited 1×
“Calothrixins A and B, are pentacyclic metabolites isolated from Calothrix cyanobacteria with anticancer potent activity against human HeLa cancer cells in a dose-dependent manner at an IC50 of 40 and 350 nM, respectively (in vitro studies) [89].”
BackgroundBiomedical potential of marine natural products
(1996) · BioScience · doi:10.2307/1312834 · Cited by 238
Medina, R. A., Goeger, D. E., Hills, P., Mooberry, S. L., Huang, N., Romero, L. I., Ortega-Barría, E., Gerwick, W. H., & McPhail, K. L. (2008) · Journal of the American Chemical Society · doi:10.1021/ja801383f · Cited by 231 · cited 2×
“Coibamide A, a promising anti-cancer agent with a new potential mechanism of action, derived from a strain of Leptolyngbya, exhibited significant cytotoxicity against NCIH460 lung and mouse neuro-2a cells (LC50 < 23 nM) [100].”
BackgroundIn vivo antimalarial activity of the beta-carboline alkaloid manzamine A
Ang, K. K. H., Holmes, M. J., Higa, T., Hamann, M. T., & Kara, U. A. K. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.6.1645-1649.2000 · Cited by 218 · cited 1×
“Advanced technology and extensive research on marine natural products have led to the discovery of a new generation of anticancer drugs currently used in clinical trials [6].”
BackgroundReher, R., Kim, H. W., Zhang, C., Mao, H. H., Wang, M., Nothias, L.-F., Caraballo-Rodriguez, A. M., Glukhov, E., Teke, B., Leao, T., et al. (2020) · Journal of the American Chemical Society · doi:10.1021/jacs.9b13786 · Cited by 215
Dring, M. J. (1991) · doi:10.1017/cbo9780511623301 · Cited by 210
An anticoagulative polysaccharide from an enzymatic hydrolysate of Ecklonia cava
Athukorala, Y., Jung, W.-K., Vasanthan, T., & Jeon, Y.-J. (2006) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2006.03.002 · Cited by 209 · cited 1×
“Sulfated polysaccharides purified from the brown alga Eclonia cava selectively and dose-dependently suppressed the proliferation of murine colon carcinoma (CT-26) and human leukemic monocyte lymphoma (U-937) cell lines [84].”
BackgroundStevenson, C. S., Capper, E. A., Roshak, A. K., Marquez, B., Eichman, C., Jackson, J. R., Mattern, M., Gerwick, W. H., Jacobs, R. S., & Marshall, L. A. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.036350 · Cited by 208 · cited 1×
“This compound regulates mitotic spindle formation as well as enzyme kinases involved in cell cycle control, and to also inhibit the proliferation of human fibroblasts and endothelial cells [103].”
Background(2011) · International Journal of Phytomedicine · Cited by 203
Highlights of marine natural products chemistry (1972–1999)
Faulkner, D. J. (2000) · Natural Product Reports · doi:10.1039/a909113k · Cited by 201 · cited 1×
“[2], have been investigated for cancer control [39,40].”
BackgroundBERGMANN, W., & BURKE, D. C. (1955) · The Journal of Organic Chemistry · doi:10.1021/jo01128a007 · Cited by 194
Yuan, Y. V., Carrington, M. F., & Walsh, N. A. (2005) · Food and Chemical Toxicology · doi:10.1016/j.fct.2005.02.012 · Cited by 188
Antitumor Active Fucoidan from the Brown Seaweed,Umitoranoo(Sargassum thunbergii)
Zhuang, C., Itoh, H., Mizuno, T., & Ito, H. (1995) · Bioscience, Biotechnology, and Biochemistry · doi:10.1271/bbb.59.563 · Cited by 184 · cited 1×
“Similarly, an extract of the brown seaweed Sargassum thunbergii displayed antitumor activity against transplanted tumor such as sarcoma 180 and Ehrlich solid carcinoma (in vivo) [77].”
BackgroundBryostatin-1: A novel PKC inhibitor in clinical development
Kortmansky, J., & Schwartz, G. K. (2003) · Cancer Investigation · doi:10.1081/cnv-120025095 · Cited by 183
Structure and absolute stereochemistry of hectochlorin, a potent stimulator of actin assembly
Marquez, B. L., Watts, K. S., Yokochi, A., Roberts, M. A., Verdier-Pinard, P., Jimenez, J. I., Hamel, E., Scheuer, P. J., & Gerwick, W. H. (2002) · Journal of Natural Products · doi:10.1021/np0106283 · Cited by 181 · cited 1×
“[100], and lyngbyabellin B, isolated from Lyngbya majuscule [182].”
BackgroundStevenson, C. S., Capper, E. A., Roshak, A. K., Marquez, B., Grace, K., Gerwick, W. H., Jacobs, R. S., & Marshall, L. A. (2002) · Inflammation Research · doi:10.1007/bf02684014 · Cited by 172 · cited 1×
“3 μM where significant inhibition was observed at concentrations as low as 300 nM [102].”
BackgroundNew dimensions in natural products research: Cultured marine microorganisms
Davidson, B. (1995) · Current Opinion in Biotechnology · doi:10.1016/0958-1669(95)80049-2 · Cited by 168 · cited 1×
“tenue [94], attributed potent cytotoxicity against human epidermoid carcinoma (LOVO) and human colorectal adenocarcinoma (KB) cell lines [95].”
BackgroundFaulkner, D. J. (2000) · Antonie van Leeuwenhoek · doi:10.1023/a:1002405815493 · Cited by 168 · cited 1×
“[2], have been investigated for cancer control [39,40].”
BackgroundZhao, M., Yang, B., Wang, J., Liu, Y., Yu, L., & Jiang, Y. (2007) · International Immunopharmacology · doi:10.1016/j.intimp.2006.09.003 · Cited by 167
Joyce, J. A., Freeman, C., Meyer-Morse, N., Parish, C. R., & Hanahan, D. (2005) · Oncogene · doi:10.1038/sj.onc.1208602 · Cited by 163
(1990) · PubMed · Cited by 161
Newman, D. J., & Cragg, G. M. (2004) · Current Medicinal Chemistry · doi:10.2174/0929867043364982 · Cited by 161
Drugs and Drug Candidates from Marine Sources: An Assessment of the Current “State of Play”
Newman, D., & Cragg, G. (2016) · Planta Medica · doi:10.1055/s-0042-101353 · Cited by 159 · cited 1×
“This research is still ongoing using advanced tools [18].”
MethodMASKEY, R. P., HELMKE, E., KAYSER, O., FIEBIG, H. H., MAIER, A., BUSCHE, A., & LAATSCH, H. (2004) · The Journal of Antibiotics · doi:10.7164/antibiotics.57.771 · Cited by 158
Moran, M. A., Rutherford, L. D., & Hodson, R. E. (1995) · Applied and Environmental Microbiology · doi:10.1128/aem.61.10.3695-3700.1995 · Cited by 152 · cited 5×
“Mansouramycin A-D and Mar. Drugs 2019, 17, 491 10 of 31 3-methyl-7-(methylamino)-5,8-isoquinolinedione, from the marine-derived Mei37 isolate of Streptomyces sp., exhibited significant cytotoxicity with a great degree of selectivity for non-small-cell lung cancer, breast cancer, melanoma, and prostate cancer cells [13…”
BackgroundInfluentialTenuecyclamides A−D, Cyclic Hexapeptides from the Cyanobacterium Nostoc spongiaeforme var. tenue
Banker, R., & Carmeli, S. (1998) · Journal of Natural Products · doi:10.1021/np980138j · Cited by 152 · cited 1×
“tenue [94], attributed potent cytotoxicity against human epidermoid carcinoma (LOVO) and human colorectal adenocarcinoma (KB) cell lines [95].”
BackgroundMarine cyanobacteria compounds with anticancer properties: A review on the implication of apoptosis
Costa, M., Costa-Rodrigues, J., Fernandes, M. H., Barros, P., Vasconcelos, V., & Martins, R. (2012) · Marine Drugs · doi:10.3390/md10102181 · Cited by 147 · cited 1×
“, exhibiting anti-proliferative effects via microfilament disruption, secretory pathway inhibition and other intracellular mechanisms [185].”
BackgroundAlbers, M. W., Williams, R. T., Brown, E. J., Tanaka, A., Hall, F. L., & Schreiber, S. L. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)41602-x · Cited by 145
New drugs from marine microbes: The tide is turning
Newman, D. J., & Hill, R. T. (2006) · Journal of Industrial Microbiology & Biotechnology · doi:10.1007/s10295-006-0115-2 · Cited by 144
Clinical status of anti-cancer agents derived from marine sources
Singh, R., Sharma, M., Joshi, P., & Rawat, D. (2008) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152008785133074 · Cited by 143
Gerwick, W. H., & Fenical, W. (1981) · The Journal of Organic Chemistry · doi:10.1021/jo00314a005 · Cited by 142 · cited 1×
“1 μg/mL, and to inhibit cells cleavage via inhibition of tubulin polymerization [85].”
BackgroundCombined LC/UV/MS and NMR Strategies for the Dereplication of Marine Natural Products
Pérez‐Victoria, I., Martín, J., & Reyes, F. (2016) · Planta Medica · doi:10.1055/s-0042-101763 · Cited by 142 · cited 1×
“Although originally used for small, relatively simple organic compounds, it has gained widespread popularity as a method for marine ́s metabolites fingerprinting organism [53,54].”
MethodMetabolomic Tools for Secondary Metabolite Discovery from Marine Microbial Symbionts
MacIntyre, L., Zhang, T., Viegelmann, C., Martinez, I., Cheng, C., Dowdells, C., Abdelmohsen, U. R., Gernert, C., Hentschel, U., & Edrada‐Ebel, R. (2014) · Marine Drugs · doi:10.3390/md12063416 · Cited by 141
Mincer, T. J., Fenical, W., & Jensen, P. R. (2005) · Applied and Environmental Microbiology · doi:10.1128/aem.71.11.7019-7028.2005 · Cited by 140
Current Status and Future Prospects of Marine Natural Products (MNPs) as Antimicrobials
Choudhary, A., Naughton, L., Montánchez, I., Dobson, A., & Rai, D. (2017) · Marine Drugs · doi:10.3390/md15090272 · Cited by 138 · cited 1×
“Consequently, a large number of natural products are in preclinical investigations, and 13 natural products isolated from marine organisms are being tested in different phases of clinical trials, highlighting the potential of marine natural compounds [25].”
Background(1997) · PubMed · Cited by 134
Role of NK cells in the antimetastatic effect of anticoagulant drugs
Gorelik, E., Bere, W. W., & Herberman, R. B. (1984) · International Journal of Cancer · doi:10.1002/ijc.2910330115 · Cited by 127
Romanenko, L. A., Uchino, M., Kalinovskaya, N. I., & Mikhailov, V. V. (2008) · Microbiological Research · doi:10.1016/j.micres.2006.10.001 · Cited by 123
Lucentamycins A−D, Cytotoxic Peptides from the Marine-Derived Actinomycete Nocardiopsis lucentensis
Cho, J. Y., Williams, P. G., Kwon, H. C., Jensen, P. R., & Fenical, W. (2007) · Journal of Natural Products · doi:10.1021/np070101b · Cited by 120
Yousaf, M., Hammond, N. L., Peng, J., Wahyuono, S., McIntosh, K. A., Charman, W. N., Mayer, A. M. S., & Hamann, M. T. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030475b · Cited by 119 · cited 2×
“Although the National Cancer Institute provides researchers with the resources needed to better elucidate the role of food and nutrients in cancer prevention, cancer chemoprevention using marine natural compounds [16,24] has not been investigated in-depth and the preclinical and clinical data for this strategy remain…”
BackgroundTwo New Xanthone Derivatives from the Algicolous Marine Fungus Wardomyces anomalus
Abdel‐Lateff, A., Klemke, C., König, G. M., & Wright, A. D. (2003) · Journal of Natural Products · doi:10.1021/np020518b · Cited by 119 · cited 1×
“[140], and (II) a xanthone derivative from Wardomyces anomalus [141].”
BackgroundMansouramycins A–D, cytotoxic isoquinolinequinones from a marine Streptomycete
Hawas, U. W., Shaaban, M., Shaaban, K. A., Speitling, M., Maier, A., Kelter, G., Fiebig, H. H., Meiners, M., Helmke, E., & Laatsch, H. (2009) · Journal of Natural Products · doi:10.1021/np900160g · Cited by 116 · cited 1×
“, exhibited significant cytotoxicity with a great degree of selectivity for non-small-cell lung cancer, breast cancer, melanoma, and prostate cancer cells [131].”
BackgroundComputational Methodologies in the Exploration of Marine Natural Product Leads
Pereira, F., & Aires‐de‐Sousa, J. (2018) · Marine Drugs · doi:10.3390/md16070236 · Cited by 116
Peng, J., Place, A. R., Yoshida, W., Anklin, C., & Hamann, M. T. (2010) · Journal of the American Chemical Society · doi:10.1021/ja9091853 · Cited by 110 · cited 1×
“Based on modern research, cultured benthic cyanobacteria from temperate marine environments provide a promising, under-exploited source for novel drugs against leukemia [107].”
BackgroundBarbier, P., Guise, S., Huitorel, P., Amade, P., Pesando, D., Briand, C., & Peyrot, V. (2001) · Life Sciences · doi:10.1016/s0024-3205(01)01396-0 · Cited by 110 · cited 1×
“algea attributed to anticancer and antiproliferative effects against neuroblastoma cell line through induction of cells inhibition proliferation with an IC50 of 10 μM [79].”
BackgroundAnti-Inflammatory and Anticancer Drugs from Nature
Orlikova, B., Legrand, N., Panning, J., Dicato, M., & Diederich, M. (2014) · Cancer Treatment and Research · doi:10.1007/978-3-642-38007-5_8 · Cited by 108 · cited 1×
“Because there is great chemical diversity in marine plants, including marine algae and mangroves, products isolated from these plants have been shown to possess antibacterial, antifungal, analgesic, anti-inflammatory, cytotoxic, hypotensive, and spasmogenic activities [68,69].”
BackgroundYu, Z., Lang, G., Kajahn, I., Schmaljohann, R., & Imhoff, J. F. (2008) · Journal of Natural Products · doi:10.1021/np070580e · Cited by 108 · cited 1×
“Two novel cyclodepsipeptides, namely, scopularide A and B, isolated from the marine fungus Scopulariopsis brevicaulis [186], significantly inhibited the growth of pancreatic and colon cancer cell lines.”
BackgroundCytotoxic and Anti-inflammatory Cembranoids from the Soft Coral Lobophytum crassum
Chao, C.-H., Wen, Z.-H., Wu, Y.-C., Yeh, H.-C., & Sheu, J.-H. (2008) · Journal of Natural Products · doi:10.1021/np8004584 · Cited by 108
ChemGPS-NPWeb: chemical space navigation online
Rosén, J., Lövgren, A., Kogej, T., Mureşan, S., Gottfries, J., & Backlund, A. (2008) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-008-9255-y · Cited by 108
Trabectedin: A Review of its Use in the Management of Soft Tissue Sarcoma and Ovarian Cancer
Carter, N. J., & Keam, S. J. (2007) · Drugs · doi:10.2165/00003495-200767150-00009 · Cited by 107
Alkaloids from a deep ocean sediment-derived fungus Penicillium sp. and their antitumor activities
Du, L., Feng, T., Zhao, B., Li, D., Cai, S., Zhu, T., Wang, F., Xiao, X., & Gu, Q. (2010) · The Journal of Antibiotics · doi:10.1038/ja.2010.11 · Cited by 106
Clinical Status of Anti-Cancer Agents Derived from Marine Sources
Singh, R. K., Sharma, M. M., Joshi, P., et al. (2008) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520610808060603 · Cited by 106
Mechanistic studies of Sansalvamide A-amide: An allosteric modulator of Hsp90
Vasko, R. C., Rodriguez, R. A., Cunningham, C. N., Ardi, V. C., Agard, D. A., & McAlpine, S. R. (2010) · ACS Medicinal Chemistry Letters · doi:10.1021/ml900003t · Cited by 105
Bhosale, S. H., Nagle, V. L., & Jagtap, T. G. (2002) · Marine Biotechnology · doi:10.1007/s10126-001-0087-1 · Cited by 104 · cited 1×
“Because there is great chemical diversity in marine plants, including marine algae and mangroves, products isolated from these plants have been shown to possess antibacterial, antifungal, analgesic, anti-inflammatory, cytotoxic, hypotensive, and spasmogenic activities [68,69].”
BackgroundThe dolastatins, a family of promising antineoplastic agents
Poncet, J. (1999) · Current Pharmaceutical Design · doi:10.2174/1381612805666230109214008 · Cited by 104
Mode of action of thiocoraline, a natural marine compound with anti-tumour activity
Erba, E., Bergamaschi, D., Ronzoni, S., Faretta, M., Taverna, S., Bonfanti, M., Catapano, C. V., Faircloth, G., Jimeno, J., & D’Incalci, M. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690451 · Cited by 103 · cited 1×
“Thiocoraline cytotoxic action was found mediated via an arrest in G1 phase of the cell cycle and a decrease in the rate of S phase progression towards G2/M phases, as assessed using bromodeoxyuridine/DNA biparametric flow cytometric analysis [117].”
MethodLophocladines, Bioactive Alkaloids from the Red Alga Lophocladia sp.
Gross, H., Goeger, D. E., Hills, P., Mooberry, S. L., Ballantine, D. L., Murray, T. F., Valeriote, F. A., & Gerwick, W. H. (2006) · Journal of Natural Products · doi:10.1021/np050519e · Cited by 103
Zhang, J.-Y., Tao, L.-Y., Liang, Y.-J., Chen, L.-M., Mi, Y.-J., Zheng, L.-S., Wang, F., She, Z.-G., Lin, Y.-C., To, K. K. W., et al. (2010) · Marine Drugs · doi:10.3390/md8041469 · Cited by 103
Self-citationSignal-transduction cascades as targets for therapeutic intervention by natural products
Cardenas, M. E., Sanfridson, A., Cutler, N. S., & Heitman, J. (1998) · Trends in Biotechnology · doi:10.1016/s0167-7799(98)01239-6 · Cited by 101
New Antioxidant Hydroquinone Derivatives from the Algicolous Marine Fungus Acremonium sp.
Abdel‐Lateff, A., König, G. M., Fisch, K. M., Höller, U., Jones, P. G., & Wright, A. D. (2002) · Journal of Natural Products · doi:10.1021/np020128p · Cited by 100
Ma, D., Zou, B., Cai, G., Hu, X., & Liu, J. O. (2006) · Chemistry – A European Journal · doi:10.1002/chem.200600599 · Cited by 99 · cited 1×
“Apratoxin A, a cyclic depsipeptide, exerted cytotoxic effects against human HeLa cervical carcinoma cells via cell cycle inhibition [181].”
BackgroundRuiz-Ruiz, C., Srivastava, G. K., Carranza, D., Mata, J. A., Llamas, I., Santamaría, M., Quesada, E., & Molina, I. J. (2011) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-010-2886-7 · Cited by 98 · cited 1×
“Only tumor cells were found susceptible to apoptosis induced by the sulphated EPS (B100S), whilst primary T cells were resistant [116].”
BackgroundMagalhaes, K. D., Costa, L. S., Fidelis, G. P., Oliveira, R. M., Nobre, L. T. D. B., Dantas-Santos, N., Camara, R. B. G., Albuquerque, I. R. L., Cordeiro, S. L., Sabry, D. A., et al. (2011) · International Journal of Molecular Sciences · doi:10.3390/ijms12053352 · Cited by 97
Anticarcinogenic, hypocholesterolemic, and antagonistic activities of Lactobacillus acidophilus
Mitall, B. K., & Garg, S. K. (1995) · Critical Reviews in Microbiology · doi:10.3109/10408419509113540 · Cited by 97
Characterization and quantification of karlotoxins by liquid chromatography–mass spectrometry
Bachvaroff, T. R., Adolf, J. E., Squier, A. H., Harvey, H. R., & Place, A. R. (2008) · Harmful Algae · doi:10.1016/j.hal.2007.10.003 · Cited by 96 · cited 1×
“Approximately half of the 41 screened strains of cyanobacteria exhibited the ability to cause cancer cell death [87].”
BackgroundYim, J. H., Son, E., Pyo, S., & Lee, H. K. (2005) · Marine Biotechnology · doi:10.1007/s10126-004-0404-6 · Cited by 96
In vivo growth-inhibition of S180 tumor by mixture of 5-Fu and low molecular ?-carrageenan from
ZHOU, G., XIN, H., SHENG, W., SUN, Y., LI, Z., & XU, Z. (2005) · Pharmacological Research · doi:10.1016/j.phrs.2004.07.003 · Cited by 95
Fischel, J.-L., Rodolphe Lemée, B., Formento, P., Caldani, C., Moll, J. L., Pesando, D., Meinesz, A., Grelier, P., Pietra, P., & Guerriero, A. (1995) · PubMed · Cited by 95
Nguyen, C. T., Dhakal, D., Pham, V. T. T., Nguyen, H. T., & Sohng, J. K. (2020) · Microorganisms · doi:10.3390/microorganisms8040616 · Cited by 92
Antioxidant, mutagenic, and antimutagenic activity of frozen fruits
Spada, P. D. S., de Souza, G. G. N., Bortolini, G. V., Henriques, J. A. P., & Salvador, M. (2008) · Journal of Medicinal Food · doi:10.1089/jmf.2007.598 · Cited by 89
The molecular pharmacology of symplostatin 1: A new antimitotic dolastatin 10 analog
Mooberry, S. L., Leal, R. M., Tinley, T. L., Luesch, H., Moore, R. E., & Corbett, T. H. (2003) · International Journal of Cancer · doi:10.1002/ijc.10982 · Cited by 87 · cited 1×
“and exhibited cytotoxic effects against human lung and breast cancer cell lines, via both Bcl-2 phosphorylation and caspase-3 protein activation [183,184].”
BackgroundMalakoff, D. (1997) · Science · doi:10.1126/science.277.5325.486 · Cited by 86 · cited 1×
“The marine environment is indeed an exceptionally diverse reservoir of life, containing nearly 250,000 described species [27,28].”
BackgroundBioactive substances produced by marine isolates of Pseudomonas
Isnansetyo, A., & Kamei, Y. (2009) · Journal of Industrial Microbiology & Biotechnology · doi:10.1007/s10295-009-0611-2 · Cited by 86 · cited 1×
“Some of these bioactive compounds are antimicrobial agents, whereas dibutyl phthalate and di-(2-ethylhexyl) phthalate have been reported to be cathepsin B inhibitors [109].”
BackgroundKalemkerian, G. P., Ou, X., Adil, M. R., Rosati, R., Khoulani, M. M., Madan, S. K., & Pettit, G. R. (1999) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800050931 · Cited by 84 · cited 1×
“and exhibited cytotoxic effects against human lung and breast cancer cell lines, via both Bcl-2 phosphorylation and caspase-3 protein activation [183,184].”
BackgroundRocha-Martin, J., Harrington, C., Dobson, A., & O'Gara, F. (2014) · Marine Drugs · doi:10.3390/md12063516 · Cited by 84 · cited 1×
“7 × 1030 microorganisms have been discovered in marine environments [29], 99% of all bacteria cannot be cultured but can synthesize many fascinating natural products that are potential drug leads [30].”
BackgroundDu, L., Zhu, T., Fang, Y., Liu, H., Gu, Q., & Zhu, W. (2007) · Tetrahedron · doi:10.1016/j.tet.2006.11.074 · Cited by 84 · cited 1×
“glaucus, contributed to the cytotoxicity against the A-549, HL-60, BEL-7402, and P388 cell lines [144], whereas alkaloids isolated from Penicillium spp.”
BackgroundLopes-Costa, E., de Abreu, M. B., Gargiulo, D., Rocha, E., & Ramos, A. A. (2017) · Journal of Toxicology and Environmental Health · doi:10.1080/15287394.2017.1357297 · Cited by 84
Marine organisms and other novel natural sources of new cancer drugs
Schwartsmann, G. (2000) · Annals of Oncology · doi:10.1093/annonc/11.suppl_3.235 · Cited by 81 · cited 1×
“Furthermore, some marine organisms, such as microflora (bacteria, actinobacteria, cyanobacteria and fungi), microalgae, macroalgae (seaweeds) [31], invertebrate animals [37,38] sponges, soft corals, sea fans, sea hares, nudibranchs, bryozoans, tunicates, etc.”
BackgroundWalsh, V., & Goodman, J. (1999) · Social Science & Medicine · doi:10.1016/s0277-9536(99)00161-6 · Cited by 78 · cited 2×
“, Taxaceae), pro ed to b useful in the treatment of breast cancer [22], in addition to the active complex alkaloid compounds such as Vincristine and Vinblastine which are present in Vinca herb.”
BackgroundChondriamides A and B, new indolic metabolites from the red alga Chondria sp.
Palermo, J. A., Flower, P. B., & Seldes, A. M. (1992) · Tetrahedron Letters · doi:10.1016/s0040-4039(00)79823-6 · Cited by 77 · cited 1×
“5 μg/mL against KB cells and 5 μg/mL against LOVO cells (colon cancer) [80].”
BackgroundBitzer, J., Große, T., Wang, L., Lang, S., Beil, W., & Zeeck, A. (2006) · The Journal of Antibiotics · doi:10.1038/ja.2006.12 · Cited by 74 · cited 1×
“strain GWS-BW-H8hM was reported to inhibit the growth of HM02 (gastric adenocarcinoma), HepG2 (hepatocellular carcinoma) and MCF7 cell lines to induce apoptosis via cell cycle arrest compared to actinomycin D [114,115].”
ResultPhysiology, biochemistry and taxonomy of deep-sea nitrile metabolising Rhodococcus strains
Heald, S. C., Brandão, P. F. B., Hardicre, R., & Bull, A. T. (2001) · Antonie van Leeuwenhoek · doi:10.1023/a:1012227302373 · Cited by 72 · cited 1×
“Marine actinomycetes include members of the genera Dietzia, Rhodococcus [119], Streptomyces [120], Salinispora [121–123], and Marinispora [120–123].”
BackgroundNovel drugs from marine microorganisms
Javed, F., Qadir, M. I., Janbaz, K. H., & Ali, M. (2011) · Critical Reviews in Microbiology · doi:10.3109/1040841x.2011.576234 · Cited by 72 · cited 1×
“, hepatocytes and cardiomyoblasts [106].”
Marine-derived angiogenesis inhibitors for cancer therapy
Wang, Y.-Q., & Miao, Z.-H. (2013) · Marine Drugs · doi:10.3390/md11030903 · Cited by 72
Cyanobacteria and microalgae: A renewable source of bioactive compounds and other chemicals
Encarnação, T., Pais, A. A. C. C., Campos, M. G., & Burrows, H. D. (2015) · Science Progress · doi:10.3184/003685015x14298590596266 · Cited by 65 · cited 1×
“Cyanobacteria, also known as blue-green algae, are prolific sources of more than 400 novel metabolites, particularly unique, biologically active peptide and polyketide metabolites [86], effective at either killing cancer cells by inducing apoptotic death or affecting cell signaling via activation of the protein kinase…”
BackgroundBose, U., Hewavitharana, A., Ng, Y., Shaw, P., Fuerst, J., & Hodson, M. (2015) · Marine Drugs · doi:10.3390/md13010249 · Cited by 64
Hereditary breast cancer: From molecular pathology to tailored therapies
Tan, D. S. P., Marchiò, C., & Reis-Filho, J. S. (2008) · Journal of Clinical Pathology · doi:10.1136/jcp.2008.057950 · Cited by 60
Pérez, M., Crespo, C., Schleissner, C., Rodríguez, P., Zúñiga, P., & Reyes, F. (2009) · Journal of Natural Products · doi:10.1021/np9006603 · Cited by 59 · cited 1×
“79 μM) compared to doxorubicin as a standard [132].”
BackgroundNeuroprotective activities of natural products from marine macroalgae during 1999–2015
Alghazwi, M., Kan, Y. Q., Zhang, W., Gai, W. P., Garson, M. J., & Smid, S. (2016) · Journal of Applied Phycology · doi:10.1007/s10811-016-0908-2 · Cited by 58 · cited 1×
“Macroalgae have long been recognized as food, functional food and potential drug sources [70].”
BackgroundNew Metabolites and Bioactive Actinomycins from Marine-Derived Streptomyces sp. ZZ338
Zhang, X., Ye, X., Chai, W., Lian, X.-Y., & Zhang, Z. (2016) · Marine Drugs · doi:10.3390/md14100181 · Cited by 58
Marine Compounds and Cancer: 2017 Updates
Dyshlovoy, S., & Honecker, F. (2018) · Marine Drugs · doi:10.3390/md16020041 · Cited by 57
Poly (β-amino ester) s promote cellular uptake of heparin and cancer cell death
Berry, D., Lynn, D. M., Sasisekharan, R., & Langer, R. (2004) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.03.023 · Cited by 56
Matsuda, M., Yamori, T., Naitoh, M., & Okutani, K. (2003) · Marine Biotechnology · doi:10.1007/s10126-002-0046-5 · Cited by 55
Enzastaurin: A lesson in drug development
Bourhill, T., Narendran, A., & Johnston, R. N. (2017) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2017.02.003 · Cited by 55
Metabolomic Profiling and Genomic Study of a Marine Sponge-Associated Streptomyces sp.
Viegelmann, C., Margassery, L. M., Kennedy, J., Zhang, T., O’Brien, C., O’Gara, F., Morrissey, J. P., Dobson, A. D. W., & Edrada‐Ebel, R. (2014) · Marine Drugs · doi:10.3390/md12063323 · Cited by 53
Neoangiogenesis Induced by Progenitor Endothelial Cells: Effect of Fucoidan from Marine Algae
Boisson‐Vidal, C., Zemani, F., Caligiuri, G., Galy–Fauroux, I., Colliec‐Jouault, S., Helley, D., & Fischer, A. (2007) · Cardiovascular & Hematological Agents in Medicinal Chemistry · doi:10.2174/187152507779315778 · Cited by 53
A phase I and pharmacokinetic study of LAF389 administered to patients with advanced cancer
Dumez, H., Gall, H., Capdeville, R., Dutreix, C., van Oosterom, A. T., & Giaccone, G. (2007) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e328010ef5b · Cited by 52
Marine biodiversity characteristics
Boeuf, G. (2011) · Comptes Rendus. Biologies · doi:10.1016/j.crvi.2011.02.009 · Cited by 52 · cited 1×
“The marine environment is indeed an exceptionally diverse reservoir of life, containing nearly 250,000 described species [27,28].”
BackgroundThe structure of leptosphaerin
Schiehser, G. A., White, J. D., Matsumoto, G., Pezzanite, J. O., & Clardy, J. (1986) · Tetrahedron Letters · doi:10.1016/s0040-4039(00)85272-7 · Cited by 49
Williams, D. E., Moore, R. E., & Paul, V. J. (1989) · Journal of Natural Products · doi:10.1021/np50064a011 · Cited by 49 · cited 1×
“and Lissoclinum patella [90–92], exhibited potent cytotoxic activity against a human nasopharyngeal carcinoma cell line at IC50 value of 17 and 3000 ng/mL, respectively [93].”
BackgroundThe synthesis and absolute configuration of (+)-leptosphaerin
Pallenberg, A. J., & White, J. D. (1986) · Tetrahedron Letters · doi:10.1016/s0040-4039(00)85273-9 · Cited by 49
Vischer, P., & Buddecke, E. (1991) · PubMed · Cited by 49
Sawadogo, W., Boly, R., Cerella, C., Teiten, M., Dicato, M., & Diederich, M. (2015) · Molecules · doi:10.3390/molecules20047097 · Cited by 49
(1987) · PubMed · Cited by 45
Perspectives in cancer chemotherapy
Garattini, S. K., & Vecchia, C. L. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00265-9 · Cited by 42
Induction of apoptosis in cancer cell lines by the Red Sea brine pool bacterial extracts
Sagar, S., Esau, L., Holtermann, K., Hikmawan, T., Zhang, G., Stingl, U., Bajic, V. B., & Kaur, M. (2013) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-13-344 · Cited by 41 · cited 2×
“israelensis (K-18) were found to be the most active at inducing apoptosis in HeLa cells [115].”
BackgroundResultParent-Massin, D. (1996) · Journal of Toxicology and Environmental Health · doi:10.1080/009841096161924 · Cited by 40
Meroterpenes from Cystoseira usneoides II
Urones, J. G., Araujo, M. E. M., Brito Palma, F. M. S., Basabe, P., Marcos, I. S., Moro, R. F., Lithgow, A. M., & Pineda, J. (1992) · Phytochemistry · doi:10.1016/0031-9422(92)80372-l · Cited by 40
Ang, K., Holmes, M. J., & KARA, U. A. K. (2001) · Parasitology Research · doi:10.1007/s004360000366 · Cited by 39
Han, B.-N., Hong, L.-L., Gu, B.-B., Sun, Y.-T., Wang, J., Liu, J.-T., & Lin, H.-W. (2019) · Symbiotic Microbiomes of Coral Reefs Sponges and Corals · doi:10.1007/978-94-024-1612-1_15 · Cited by 39
Kim, W., Kim, Y., Kim, J., Nam, B.-H., Kim, D.-G., An, C., Lee, J., Kim, P., Lee, H., Oh, J.-S., et al. (2016) · Marine Drugs · doi:10.3390/md14010024 · Cited by 37
Freitas, S., Martins, R., Costa, M., Leão, P., Vitorino, R., Vasconcelos, V., & Urbatzka, R. (2016) · Marine Drugs · doi:10.3390/md14090158 · Cited by 37
Gross, H., Kehraus, S., Nett, M., König, G. M., Beil, W., & Wright, A. D. (2003) · Organic & Biomolecular Chemistry · doi:10.1039/b210039h · Cited by 36
Signal transduction pathway targets for anticancer drug discovery
Adjei, A. (2000) · Current Pharmaceutical Design · doi:10.2174/1381612003400821 · Cited by 33
Krock, B., Busch, J., Tillmann, U., García-Camacho, F., Sánchez-Mirón, A., Gallardo-Rodríguez, J., López-Rosales, L., Andree, K., Fernández-Tejedor, M., Witt, M., et al. (2017) · Marine Drugs · doi:10.3390/md15120391 · Cited by 33
Aureolic acids from a marine-derived Streptomyces sp. WBF16
Lu, J., Ma, Y., Liang, J., Xing, Y., Xi, T., & Lu, Y. (2012) · Microbiological Research · doi:10.1016/j.micres.2012.06.001 · Cited by 32
Pathak, S., Multani, A. S., Ozen, M., Richardson, M. A., & Newman, R. A. (1998) · Oncology Reports · doi:10.3892/or.5.2.373 · Cited by 32 · cited 1×
“Moreover, ET-743, a tetrahydroisoquinilone alkaloid isolated from tunicate Ecteinascidia turbinata entered phase I clinical trials [62], since it exerts anti-proliferative effects by selective alkylation of guanine residues in the DNA minor groove [63], whereas dolastatin 10, a member of a peptide family isolated from…”
BackgroundNew myrsinol-related polyfunctional pentacyclic diterpene esters from roots of Euphorbia prolifera
Wu, D., Sorg, B., & Hecker, E. (1995) · Journal of Natural Products · doi:10.1021/np50117a009 · Cited by 32
Antibacterial effect of the red sea soft coral Sarcophyton trocheliophorum
Gomaa, M. N., Soliman, K., Ayesh, A., Abd El-Wahed, A., Hamza, Z., Mansour, H. M., Khalifa, S. A. M., Mohd Ali, H. B., & El-Seedi, H. R. (2016) · Natural Product Research · doi:10.1080/14786419.2015.1040991 · Cited by 31
Self-citationSofrona, E., Tziveleka, L., Harizani, M., Koroli, P., Sfiniadakis, I., Roussis, V., Rallis, M. C., & Ioannou, E. (2020) · Marine Drugs · doi:10.3390/md18040219 · Cited by 31
Kale, V., Freysdottir, J., Paulsen, B. S., Friðjónsson, Ó. H., Óli Hreggviðsson, G., & Omarsdottir, S. (2013) · Bioactive Carbohydrates and Dietary Fibre · doi:10.1016/j.bcdf.2013.09.009 · Cited by 29
Guerriero, A., D'Ambrosio, M., Cuomo, V., & Pietra, F. (1991) · Helvetica Chimica Acta · doi:10.1002/hlca.19910740707 · Cited by 28
Wall, N. R., Mohammad, R. M., Reddy, K. B., & Al-Katib, A. M. (2000) · International Journal of Molecular Medicine · doi:10.3892/ijmm.5.2.165 · Cited by 28
Zovko, A., Novak, M., Hååg, P., Kovalerchick, D., Holmlund, T., Färnegårdh, K., Ilan, M., Carmeli, S., Lewensohn, R., & Viktorsson, K. (2016) · Oncotarget · doi:10.18632/oncotarget.10361 · Cited by 28
Fischel, J. L., Rodolphe Lemée, B., Formento, P., et al. (1995) · Iris (University of Trento) · Cited by 28
Enhancement of mixed leukocyte reaction and cytotoxic antitumor responses by heparin
Dziarski, R. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.143.1.356 · Cited by 26
Biological and Chemical Diversity of Bacteria Associated with a Marine Flatworm
Lin, H.-N., Wang, K.-L., Wu, Z.-H., Tian, R.-M., Liu, G.-Z., & Xu, Y. (2017) · Marine Drugs · doi:10.3390/md15090281 · Cited by 26
MARINE ALGAL STEROL HYDROCARBON WITH ANTI-INFLAMMATORY, ANTICANCER AND ANTI-OXIDANT PROPERTIES
Ibrahim, E. A., Aly, H. F., Baker, D. H. A., Mahmoud, K. M., & El‐Baz, F. (2016) · International Journal of Pharma and Bio Sciences · Cited by 24
New Cytotoxic Natural Products from the Red Sea Sponge Stylissa carteri
Abdelhameed, R. F. A., Habib, E. S., Eltahawy, N. A., et al. (2020) · Marine Drugs · doi:10.3390/md18050241 · Cited by 24
Muigg, P., Rosén, J., Bohlin, L., & Backlund, A. (2013) · Phytochemistry Reviews · doi:10.1007/s11101-012-9256-2 · Cited by 22
Panagiotopoulos, C., Repeta, D. J., Mathieu, L., Rontani, J.-F., & Sempéré, R. (2013) · Marine Chemistry · doi:10.1016/j.marchem.2013.04.003 · Cited by 22
(2013) · Cited by 22
(2000) · PubMed · Cited by 21
Drug Addiction: From Basic Research to Therapy
White, J. (2009) · Drug and Alcohol Review · doi:10.1111/j.1465-3362.2009.00088_1.x · Cited by 20 · cited 1×
“Eighty-seven percent of human diseases, including cancer, are treated using natural products [15].”
Background(2006) · Cited by 20
Novel tricyclic diterpenoids from Euphorbia micractina
Shi, J.-G., Jia, Z.-J., & Cui, Y.-X. (1995) · Journal of Natural Products · doi:10.1021/np50115a006 · Cited by 18
(2001) · Natural Product Sciences · Cited by 18
Morvan, D. (2013) · Marine Drugs · doi:10.3390/md11103846 · Cited by 17 · cited 1×
“For example, functional metabolomics was employed to reveal metabolic alterations associated in MCF-7 breast cancer cells exposed to the alkaloid ascididemin [56].”
Method
Research works printed but not linked: 7
- Whitman, 1998, The unseen majority, Proc. Natl. Acad. Sci. USA, 74, 5088
- Reyes, 2002, The marine pharmacy: New antitumoral compounds from the sea, Pharm. News, 9, 495
- Laatsch, H. (2011). AntiBase 2011: The Natural Compound Identifier, Wiley-Vch.
- Harmon, 2000, Ecteinascidin-743 (et-743) induces objective responses and disease control in patients with advanced non-osseous sarcomas: Results from phase Ii trials, Ann. Oncol., 11, 126
- Lavakumar, 2012, Anticancer and antioxidant effect of Acanthophora spicifera against EAC induced carcinoma in mice, J. Pharm. Res., 5, 1503
- Suja, 2014, Anticancer activity of compounds isolated from marine endophytic fungus Aspergillus terreus, World J. Pharm. Pharm. Sci., 3, 661
- Devi, 2015, Molecular modeling, quantitative structure activity relationship and pharmacophore studies on antiǧviral, antiǧmalarial and antiǧinflammatory bioactive compounds from marine sources, Asian J. Pharm. Clin. Res., 8, 36
Cited by
Review on natural products databases: where to find data in 2020
Sorokina, M., & Steinbeck, C. (2020) · Journal of Cheminformatics · doi:10.1186/s13321-020-00424-9 · Cited by 485
“The Dictionary of Natural products (DNP) [25] and it’s autonomous sub-sections, the Dictionary of Marine Natural Products (DNMP) [28] and the Dictionary of Food Compounds [29], are the considered as the most complete and best-curated resources for NP. NaprAlert [30] was created by researchers at the University of Chic…”
BackgroundInfluentialMicroalgae: therapeutic potentials and applications
Khavari, F., Saidijam, M., Taheri, M., & Nouri, F. (2021) · Molecular Biology Reports · doi:10.1007/s11033-021-06422-w · Cited by 257
“Bioactive compounds of blue-green algae can induce apoptosis and activate the protein kinase-c family in cancer cells [55].”
BackgroundReher, R., Kim, H. W., Zhang, C., Mao, H. H., Wang, M., Nothias, L.-F., Caraballo-Rodriguez, A. M., Glukhov, E., Teke, B., Leao, T., et al. (2020) · Journal of the American Chemical Society · doi:10.1021/jacs.9b13786 · Cited by 215
Biomaterials from the sea: Future building blocks for biomedical applications
Wan, M.-C., Qin, W., Lei, C., Li, Q.-H., Meng, M., Fang, M., Song, W., Chen, J.-H., Tay, F., & Niu, L.-N. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2021.04.028 · Cited by 171
Self-citationCurcumin-Based Nanoformulations: A Promising Adjuvant towards Cancer Treatment
Ghoran, S. H., Calcaterra, A., Abbasi, M., Taktaz, F., Nieselt, K., & Babaei, E. (2022) · Molecules · doi:10.3390/molecules27165236 · Cited by 160
“Due to their biochemical structures, natural compounds can affect numerous cellular targets, such as genes and proteins [4,5].”
Background
Metadata
- Authors
- Khalifa, S. A. M., Elias, N., Farag, M. A., Chen, L., Saeed, A., Hegazy, M.-E. F., Moustafa, M. S., Abd El-Wahed, A., Al-Mousawi, S. M., Musharraf, S. G., Chang, F.-R., Iwasaki, A., Suenaga, K., Alajlani, M., Göransson, U., & El-Seedi, H. R.
- Affiliations
- Karolinska University Hospital (SE)
- University of Kalamoon (SY)
- Cairo University (EG)
- Fujian Agriculture and Forestry University (CN)
- Quaid-i-Azam University (PK)
- Johannes Gutenberg University Mainz (DE)
- Kuwait University (KW)
- Department of Chemistry, Faculty of Science, University of Kuwait, 13060 Safat, Kuwait
- University of Karachi (PK)
- Kaohsiung Medical University (TW)
- Keio University (JP)
- Uppsala University (SE)
- Jiangsu University (CN)
- Corresponding author
- El-Seedi, Hesham R.
- ORCID
- Venue
- Marine Drugs
- Publisher
- MDPI AG
- Published
- 2019-08-23
- Volume
- 17
- Issue
- 9
- Pages
- 491
- ISSN
- 1660-3397 (ISSN-L)
- PMC
- PMC6780632
- OpenAlex
- W2969876208
- Semantic Scholar
- fc04613de468c55e3c00acaa04bbf85967f96088
- Cited by
- 555
- References
- 235
- Citations by year
- 2026: 32 · 2025: 73 · 2024: 100 · 2023: 88 · 2022: 109 · 2021: 98 · 2020: 49 · 2019: 4
- FWCI
- 6.25
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Marine Drugs (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Uppsala University Publications (Uppsala University) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Uppsala University (Swedish Research links grant 2016-05885 (VR for the years 2017 - 2019))
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Marine Sponges and Natural Products
- Life Sciences › Agricultural and Biological Sciences › Aquatic Science › Seaweed-derived Bioactive Compounds
- Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Microbial Natural Products and Biosynthesis
- Keywords
- marine natural products, anticancer agents, marine organisms, marine algae, marine bacteria, actinomycetes, marine fungi, marine sponges, soft coral, marine plants, apoptosis, cytotoxicity, cancer prevention, molecular mechanisms, bioactive metabolites, anticancer drug discovery
- MeSH terms
- Animals, Antineoplastic Agents, Biological Products, Clinical Trials as Topic, Disease Models, Animal, Humans, Neoplasms, Treatment Outcome, Aquatic Organisms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.